ArticleFrontiers in nuclear medicine2026
Dual-domain transformer-based learned primal-dual reconstruction for PET imaging.
Article in Frontiers in nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Positron Emission Tomography (PET) is widely used for assessing metabolic activity and diagnosing cancer. Due to the inherently high noise levels in PET data, advanced reconstruction algorithms are essential for accurate imaging. Convolutional Neural Networks (CNNs) within the Learned Primal-Dual (LPD) framework have shown good performance for PET reconstruction; however, the locality assumption imposed by CNNs can limit their ability to capture long-range contextual dependencies in sinogram data. Motivated by our previous work on transformer-based architecture for low-dose and low-count sinogram denoising, we comprehensively investigate the integration of attention mechanisms, both self-attention and cross-attention, within the LPD framework. Methods: We propose and evaluate three novel transformer-based LPD architectures: the Dual-Domain Stacked Transformer-based LPD, which employs sinusoidal patches to model long-range dependencies in the dual domain (sinogram); the Dual-Domain Restormer-based LPD, a hybrid design that combines CNNs for fine-grained local feature extraction with transformers for global information exchange; and the Dual-Domain UNet-based LPD incorporating Cross-Attention mechanism, which augments the U-Net LPD with cross-attention to capture complementary information across image and sinogram domains. To enable robust transfer learning, we further introduce a system-aligned synthetic data generation process that replicates the MiniPET-3 system, our in-house preclinical PET scanner dedicated to small-animal imaging, incorporating realistic acquisition geometry, resolution blurring, positron range effects, and Poisson noise. Results: Evaluations on synthetic data demonstrate that both the Stacked Transformer-based LPD and Dual-Domain Restormer-based LPD outperform the UNet-based LPD baseline in MSE and PSNR across all noise levels, with the Restormer additionally achieving higher SSIM at low noise. The UNet-based LPD incorporating a cross-attention mechanism also improves MSE and PSNR over the baseline, while exhibiting a slight reduction in SSIM, indicating a trade-off between pixel-wise accuracy and structural similarity. Trained exclusively on synthetic data, the proposed models generalize well to experimental measurements, producing high-quality reconstructions. Conclusions: Overall, this work highlights the promise of transformer-integrated LPD frameworks for enhancing PET reconstruction quality and robustness in low-count imaging settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.